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Peripheral Intravenous Cannula Usage in the Emergency Department 
 
Over a billion peripheral intravenous cannulas (PIVC) are used globally every year with at least 25 million 
sold annually in the UK.1,2 The NHS spends an estimated £29m of its annual acute sector budget on PIVC 
procurement3 and around 70% of all hospitalised patients require at least one PIVC during their stay.4 
Despite their extensive and routine use, PIVC failure rates are reported as high as 50-69%.5-7 In addition, 
many PIVCs remain unused following insertion, particularly in the Emergency Department (ED).8,9 The risk 
factors for PIVC failure are not well understood and the literature has found extensive regional variation in 
practice when it comes to PIVC insertion and management.1,7,10 While various technologies have been 
developed to address these issues, there remains a need for standardised, evidence-based guidelines. 
 
We conducted a semi-structured healthcare questionnaire survey in the Royal Infirmary of Edinburgh ED 
which aimed to evaluate the failure rate of PIVCs inserted pre-hospital and in the ED and identify factors 
associated with failure. Failure was defined as loss of PIVC function due to extravasation, phlebitis or 
occlusion. Cannula, patient, inserter and location data were collected over a 6-week period. It was also 
noted whether each PIVC had been documented on the Electronic Patient Record (EPR) system, which 
contains a questionnaire template to be completed following PIVC insertion. Patients were followed up 
daily for the duration of their hospital stay. In the event of cannula removal, the reason was recorded in 
addition to the duration of PIVC survival. Data collection was carried out on weekdays between the hours 
of 8am to 6pm. Patients were approached by (AS) and invited to enrol in the study, after which data was 
captured in a standardised manner using a data and questionnaire sheet (see appendix). All patients were 
assigned anonymous identification numbers stored on a password protected drive and all patient data was 
anonymised prior to NHS release. This service evaluation survey was deemed by the South East Scotland 
Research Ethics Service (SESRES) not to require formal ethics review and was registered with the Edinburgh 
Quality Improvement Projects in the ED (eQuIPED) registry. Pearson’s Chi-squared test was used to 
compare factors associated with PIVC failure and log-rank tests to compare factors associated with PIVC 
survival. Statistical analysis was conducted using IBM SPSS Statistics version 24.0. 
 
Data were collected on a convenience sample of 104 patients with 119 PIVCs between 27.01.20 and 
06.03.20. 90 PIVCs (75.6%) were inserted in the ED and 29 (24.4%) were inserted pre-hospital. Nurses 
inserted the largest proportion of PIVCs (n=49, 41.2%), followed by doctors (n=35, 29.4%), paramedics 
(n=29, 24.4%), physician associates (n=4, 3.4%) and medical students (n=2, 1.7%). The antecubital fossa 
was the most common insertion site (n=62, 52.1%) followed by the posterior hand (n=27, 22.7%), wrist 
(n=15, 12.6%), forearm (n=13, 10.9%), upper arm (n=1, 0.8%) and finger (n=1, 0.8%). 61 PIVCs (51.3%) were 
inserted in the non-dominant arm, with 58 (48.7%) in the dominant arm. Preferred PIVC gauge was 20G 
(n=78, 65.5%), followed by 18G (n=28, 23.5%), 22G (n=9, 7.6%) and 16G (n=4, 3.4%). Only 26 PIVCs (21.8%) 
were documented on the EPR system. 
 
33 PIVCs (27.7%) failed, with 15 (12.6%) routinely removed or no longer required and 13 (10.9%) removed 
for undefined reasons. In patients admitted, 29 PIVCs (42.6%) failed, with 15 (22.1%) removed routinely 
and 11 (16.2%) undefined. PIVC failure was associated with dominant arm insertion (p=0.011) and pre-
hospital insertion (p=0.001). Log-rank tests revealed that cumulative PIVC survival was lower in dominant 
arm (p=0.01) and pre-hospital insertions (p<0.001). Kaplan-Meier curves are shown in the Figure.  
 
In conclusion, we found a high PIVC failure rate (43%) in admitted patients. Dominant arm and pre-hospital 
insertion were significantly associated with PIVC failure and this is consistent with previous research.6 
Based on these results, we would suggest that dominant arm insertion should be avoided where possible. 
Pre-hospital insertion should only be undertaken if deemed necessary rather than routine, whilst 
acknowledging that patients are often undifferentiated and at high risk of deterioration, meaning a lower 
threshold for PIVC insertion is not unreasonably common practice. While guidance suggests that PIVCs 
should last at least 3 to 4 days if clean and not infected, our results show earlier drops in PIVC survival. The 
largest drop was observed on day 2, by which time patients had all been transferred to the Acute Medical 
Unit and/or downstream wards. Further research is needed to investigate PIVC management on the wards 
and the effects of patient transfer on PIVC survival. PIVC failure was not significantly associated with 
admission to any specific downstream wards. However, we were unable to determine whether specific 
pathologies amongst patients contributed towards PIVC failure. Therefore, further research investigating 
the relationship between disease and PIVC survival would be useful. Overall, our findings highlight the 
prominence of PIVC failure and together with other published research can begin to inform the 
development of standardised guidelines, essential to control the extensive variation in practice and high 
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Appendix: Data and questionnaire sheet 
 
